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In all patients a1-antitrypsin serum levels were normal
(median 1.6 g/l). High resolution CT-scan showed that the
emphysema was paraseptal in distribution and hence quite
distinct from the more uniformly distributed bullae of
centrilobular emphysema, typical changes associated with a
lifetime of tobacco smoking. However CMS had multiple and
larger emphysematous bullae with pleural thickening (size
12 cm) thanMSaffectedby small bilateral bullae (size from0.5
to 7 cm). Spirometric tests of CMS confirmed reduced FVC and
FEV1 value with a reduced FEV1/FVC ratio suggesting mild
airways obstruction in contrast to normal values of MS. All
patients were treated by VATS for prevention of relapsing
pneumothorax. Bullectomy specimen of MS illustrated minor
accumulation of pigmented histiocytes (smoker’s macro-
phages) than of CMS where we found a coarser brown to
black pigment [4]. The postoperative course of MS was
unremarkable while CMS had prolonged air leaks and in one
case was performed pleurectomy by thoracotomy. In contrast
to Beshay who showed no difference among all patients of
group I, we noted several differences for clinical, radiological
and histopathological evaluation and in the postoperative
course of CMS compared to MS. These observations suggest
that cocaine, when smoked together with marijuana, might
aggravate marijuana-induced lung injury. Is it coincidence?
Fligiel and colleagues reported that the effects of cocaine and
marijuana on the airway appear not to be additive [5].
However the authors report histopathologic features of
mucosal biopsy but do not include alveolar lung tissue and
bullous disease. Probably noxious components that are a
mixture of cocaine smoke plus components included in
marijuana smoke might stimulate an amplified inflammation
response with a dramatic increase of injurious effects on the
alveolar lung. Finally in the light of this hypothesis, further
studies are required to assess the effects of marijuana when
smoked by itself and in conjunctionwith other illicit substance
on lung parenchyma.
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We thank Dr Fiorello [1] and his group for the additional
information on the topic [2] and we assume we are not the
only thoracic centre seeing this type of lung injury. It is true
that we do not exactly know what these patients are smoking
and additives as lead, talcum or other substances to increase
weight when selling these drugs have been reported and it is
of course difficult to identify the additives retrospectively in
a specific patient.
We have to pay attention to this problem but also have to
ask the question, as in a recent editorial in the European
Respiratory Journal: ‘Cannabis: the next villain on the lung
cancer battlefield?’ [3].
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We read with great interest the article of Lucchi et al. [1]
on surgical treatment of pleural recurrence of thymoma. As
such recurrences are rare we want to add an additional case
we recently encountered [2]. Recurrent myasthenia gravis
was observed in a 43-year-old patient 3 years after radical
thymectomy for which a partial pericardial resection had
been necessary to obtain a complete resection. An isolated
pleural recurrence was discovered above the left diaphragm
which could be removed by video-assisted thoracic surgery
